Biomaterial Strategies for Targeted Intracellular Delivery to Phagocytes
Phagocytes are essential to a functional immune system, and their behavior defines disease outcomes. Engineered particles offer a strategic opportunity to target phagocytes, harnessing inflammatory modulation in disease. By tuning features like size, shape, and surface, these systems can modulate immune responses and improve targeted treatment for a ...
Kaitlyn E. Woodworth +2 more
wiley +1 more source
A case of adult granulosa cell tumor of the ovary with long-term survival after multiple recurrences
Objective: To illustrate the clinical course of a rare case of recurrent adult granulosa cell tumor (AGCT) and discuss the features and management for recurrences. Case report: A 56-year-old female was first diagnosed with AGCT in 2008 and had uneventful,
Angel Hsin-Yu Pai +5 more
doaj +1 more source
This paper describes the development of an upconverting particle‐integrated microneedle patch that can release the hormone leuprolide when the patch is exposed to near‐infrared light. This system represents proof‐of‐concept of a painless and automated method of delivering drugs at specific times when repeated time‐sensitive injections are required ...
Vivienne Tam +8 more
wiley +1 more source
A Case of Hemothorax as Manifestation of Thoracic Endometrial Syndrome
Thoracic endometriosis is a rare progression of a mostly benign disease of ectopic endometrial activity involving the pleura and lung. This is a case of a young female who presented with progressive shortness of breath and was found to have significant ...
Sandra Patrucco Reyes MD +3 more
doaj +1 more source
The role of gonadotrophin-releasing hormone antagonists in the treatment of patients with advanced hormone-dependent prostate cancer in the UK. [PDF]
PURPOSE: Comparing gonadotrophin-releasing hormone (GnRH) antagonists and agonists as androgen deprivation therapy for advanced prostate cancer (PC). METHODS: This article stems from a round-table meeting in December 2014 to compare the properties of ...
A Nanda +55 more
core +2 more sources
Gender‐affirming hormone therapy: Effect on semen quality and use of fertility preservation
Abstract Fertility preservation (FP) is a fundamental part of gender care. Gender‐affirming hormone therapy (GAHT) involves the use of drugs that could be potential risk factors for fertility. Therefore, FP is recommended before beginning the gender‐affirmation process.
Anna Chiara Conflitti +7 more
wiley +1 more source
Balancing selected medication costs with total number of daily injections: a preference analysis of GnRH-agonist and antagonist protocols by IVF patients [PDF]
Background During in vitro fertilization (IVF), fertility patients are expected to self-administer many injections as part of this treatment. While newer medications have been developed to substantially reduce the number of these injections, such agents ...
Sills, E.S. +11 more
core +2 more sources
Objective Sperm DNA fragmentation (SDF) may influence embryonic development during in vitro fertilization (IVF) treatment. This study examined the relationship between SDF and embryonic development and correlations between SDF and semen parameters.
Yu-Li Chuang +7 more
wiley +1 more source
INDUCTION OF FERTILE OESTRUS IN BITCHES USING A SUSTAINED RELEASE PREPARATION OF A GnRH ANALOGUE - LEUPROLIDE ACETATE [PDF]
Anoestrus bitches were treated with a sustained release preparation of Leuprolide acetate @ 100 Ng/kg body weight followed by gonadorelin @ 3 flg/kg body weight on the first day of induced oestrus.
B. Bibin Becha, K. N. Aravinda Ghosh
doaj
Overnight levels of luteinizing hormone, follicle-stimulating hormone and growth hormone before and during gonadotropin-releasing hormone analogue treatment in short boys born small for gestational age [PDF]
Aims: To evaluate if 3 months of gonadotropin-releasing hormone analogue (GnRHa) treatment results in sufficient suppression of pubertal luteinizing hormone (LH) and follicle-stimulating hormone (FSH) profile patterns in short pubertal small for ...
Bakker-Van Waarde, W.M. (Willie) +6 more
core +3 more sources

